Brolucizumab Receives FDA Approval for Wet AMD

By http://www.midatlanticretina.com/author
October 8, 2019

Carl Regillo, MD was interviewed by MD Magazine to discuss the clinical usage of the new anti-VEGF injection treatment, brolucizumab (Beovu), that has been approved by the FDA for the treatment of Wet Macular Degeneration.

Category:


Comments are closed.